On the morning of December 5, 2024, at the Pavillon Convention Center – Tan Son Nhat Hotel, the Opening Ceremony of the 27th Annual Cancer Prevention Conference in Ho Chi Minh City was held, co-organized by Ho Chi Minh City Oncology Hospital, Vietnam Cancer Association, Ho Chi Minh City Cancer Association and Central Cancer Hospital.
This year’s conference was attended by more than 2,000 guests, including experts, researchers, doctors and representatives of hospitals, medical organizations, universities and research centers at home and abroad. In particular, the conference had the participation of more than 14 international reporters from countries such as the US, France, Japan, Russia, Korea, Belgium and Singapore, bringing new, updated research and the most advanced treatment methods in the field of oncology.
Annual Cancer Prevention Conference in Ho Chi Minh City The 27th Ho Chi Minh City Conference is an opportunity for domestic and foreign colleagues to look back, share, and summarize experiences from research, practical application of medical advances, and plan strategies for developing the oncology profession in the future, continuing the success of the past 26 conferences.
In 02 days 05 and 06/12/2024, there are 21 thematic conference sessions including: 01 Plenary session, 20 thematic sessions on various types of cancer and many specialized issues (Hepatology – Gallbladder, Digestion, Hematology, General, Radiation therapy – Radiation techniques Lung – Thoracic, Head and neck, Nursing – Palliative care, Breast, Gynecology – Urology, Pathology) and 6 satellite conference sessions are held.
In addition to the thematic seminars, the conference also organized activities such as exhibitions of poster reports, medical equipment, new technologies supporting the detection and treatment of cancer, attracting the attention of many visitors.
Viet-Phap is very proud to be a sponsor and companion of this conference. The company also brought to the conference core products in cancer treatment such as Akynzeo® (Netupitant 300mg, Palonosetron 0.5mg) to help prevent acute and late nausea and vomiting caused by chemotherapy and other products such as Abiraterone, Aloxi, Spectrila, Erwinase, Bortezomib,… In particular, Akynzeo was introduced in more depth through the report of Dr. Phan Thi Hong Duc (Breast, Liver, Digestive Department) at the conference with the topic: The effectiveness of the combination of 5-HT3 + NK1 in preventing CINV.
